CD8A and neoplasm: Type I IFNs stimulate the activation of DCs following engulfment of apoptotic tumor cells, sustain tumor antigen‐bearing DCs survival, and enhance antigen cross‐presentation leading to CD8+ T‐cell cross‐priming [64].